These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1465924)

  • 1. Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.
    Traindl O; Reading S; Franz M; Falger S; Klauser R; Gisinger J; Widhalm K; Kovarik J
    Transplant Proc; 1992 Dec; 24(6):2745-7. PubMed ID: 1465924
    [No Abstract]   [Full Text] [Related]  

  • 2. Lovastatin treatment of hyperlipidemia in kidney transplant recipients on cyclosporine immunosuppression.
    Kandus A; Kovac D; Koselj M; Kveder R; Bren AF
    Transplant Proc; 1994 Oct; 26(5):2642-3. PubMed ID: 7940824
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
    Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T
    Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid and lipoprotein(a) in renal transplant recipients.
    Sugahara S; Koyama I; Yoshikawa Y; Dohi Y; Omoto R
    Transplant Proc; 1994 Aug; 26(4):2080-1. PubMed ID: 8066678
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
    Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoprotein(a) concentrations in chronic renal failure and following renal transplantation.
    Yang CW; Kim YS; Kim SY; Choi EJ; Chang YS; Yoon YS; Bang BK; Koh YB
    Transplant Proc; 1994 Aug; 26(4):2082-3. PubMed ID: 8066679
    [No Abstract]   [Full Text] [Related]  

  • 7. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring of lipid anomalies in renal transplantation].
    Mourad G; Vela C; Cristol JP
    Nephrologie; 2000; 21(7):365-6. PubMed ID: 11200613
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N; Ohmori Y; Tsuji T; Oka T
    Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract]   [Full Text] [Related]  

  • 10. Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation.
    Hidalgo L; Zambrana JL; Blanco-Molina A; López-Granados A; Concha M; Casares J; Jiménez-Pérez J; López-Miranda J; Pérez-Jiménez F
    J Heart Lung Transplant; 1995; 14(3):461-7. PubMed ID: 7654731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
    Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
    Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestatic jaundice associated with lovastatin (Mevacor) therapy.
    McQueen MJ
    CMAJ; 1990 Apr; 142(8):841-2. PubMed ID: 2322916
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of lovastatin and bezafibrate on cyclosporine-induced hyperlipidemia in rabbits.
    Hidalgo L; López-Miranda J; Espino A; Alcala J; Blanco J; Prada JL; Rodríguez M; Jiménez-Perepérez JA; Jansen S; Pérez-Jiménez F
    Transplant Proc; 1995 Apr; 27(2):1857-61. PubMed ID: 7725532
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperlipidemia in stable renal transplant recipients.
    Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Chirawong P; Vanichakarn S; Nimmannit S; Ong-Ajyooth S; Nilwarangkur S
    Transplant Proc; 1994 Aug; 26(4):2062-4. PubMed ID: 8066670
    [No Abstract]   [Full Text] [Related]  

  • 16. Dislipidemia at different immunosuppressive protocols.
    Zezina L; Rosental R
    Transplant Proc; 1994 Dec; 26(6):3223. PubMed ID: 7998123
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of primary mixed hyperlipidemia with lovastatin.
    Vega GL; Grundy SM
    Arch Intern Med; 1990 Jun; 150(6):1313-9. PubMed ID: 2353864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on post-transplant dyslipidemia in kidney transplant patients.
    Marubayashi S; Ohdan H; Tashiro H; Tokita D; Onoe T; Hayamizu K; Asahara T; Doi S; Okumoto S; Tanji C; Kawai T; Taniguchi Y; Fukuda Y; Dohi K
    Hiroshima J Med Sci; 2005 Jun; 54(2):39-45. PubMed ID: 15991596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.